{"version":"1.0","provider_name":"MedCity INVEST PharmaTech","provider_url":"https:\/\/events.medcitynews.com\/invest-pharmatech","author_name":"Laura Kittredge","author_url":"https:\/\/events.medcitynews.com\/invest-pharmatech\/author\/lkittredge\/","title":"Chris Gibson, PhD - MedCity INVEST PharmaTech","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"jGGjI536xr\"><a href=\"https:\/\/events.medcitynews.com\/invest-pharmatech\/speakers\/chris-gibson\/\">Chris Gibson, PhD<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/events.medcitynews.com\/invest-pharmatech\/speakers\/chris-gibson\/embed\/#?secret=jGGjI536xr\" width=\"600\" height=\"338\" title=\"&#8220;Chris Gibson, PhD&#8221; &#8212; MedCity INVEST PharmaTech\" data-secret=\"jGGjI536xr\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/events.medcitynews.com\/invest-pharmatech\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/events.medcitynews.com\/uploads\/sites\/3\/2022\/05\/Recursion-Chris-Gibson-731x1024.jpeg","thumbnail_width":731,"thumbnail_height":1024,"description":"Chris Gibson, PhD, is the Co-Founder and CEO of Recursion (NASDAQ:RXRX), a clinical-stage pharmatech company leveraging the latest in automation and artificial intelligence to map and navigate biology and chemistry to discover and develop new medicines at scale. Chris developed the technology and approach that seeded Recursion as part of his MD\/PhD work in the&hellip;"}